"""Generate Idiopathic Short Stature essay DOCX with strict formatting requirements."""
from __future__ import annotations

from docx import Document
from docx.enum.text import WD_ALIGN_PARAGRAPH, WD_LINE_SPACING
from docx.shared import Inches, Pt

ESSAY_TEXT = """[
Comprehensive Perspectives on Idiopathic Short Stature: An Academic Essay for Medical Trainees
Prepared for: Mansoura University – Faculty of Medicine
Student: [Your Name Here]
Course: [Course Name]
Date: [Month, Year]


---

1. Introduction

Idiopathic short stature (ISS) is usually defined as height more than two standard deviations below the mean for age and sex, in a child who has no identifiable chronic disease, endocrine disorder, or nutritional deficiency. In practice, ISS is a working label used when the main known causes of growth failure have been excluded, but the exact biological explanation remains uncertain. This definition guides current guidelines on how to investigate and treat affected children and highlights the need for careful monitoring rather than a single one-time decision.
Reference: Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature. J Clin Endocrinol Metab. 2008;93(11):4210–4217.

Clinically, ISS is common in pediatric endocrine clinics, but relatively few short children in the community are ever referred. Which child is investigated often depends on parental concern, school or primary-care observations, and local healthcare access. This means that ISS is not only a biological diagnosis but also a social and system-level phenomenon.

For medical trainees, ISS is a useful model of how to handle diagnostic uncertainty. It demands good history-taking, repeated measurements, and clear explanations to families about what is known, what is not yet known, and why follow-up is important. It also forces the clinician to think about psychosocial aspects and cost, not only centimeters of height.


---

2. Normal Growth and Physiology

Normal linear growth is driven by a combination of genetics, nutrition, hormones, and the local biology of the growth plate. The growth hormone (GH)–insulin-like growth factor-1 (IGF-1) axis plays a central role: GH secreted in pulses from the pituitary stimulates hepatic and local IGF-1 production, which then acts on growth plate chondrocytes to support proliferation and hypertrophy. Understanding this axis helps clinicians interpret IGF-1 levels, GH stimulation tests, and the likely response to therapy in children being evaluated for short stature.
Reference: Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. Pediatr Clin North Am. 2015;62(4):1019–1036.

Growth does not proceed at a constant speed. There is rapid growth in infancy, a slower but steady phase in mid-childhood, and a pubertal growth spurt. Disruption at any stage, even by a modest amount, can affect final adult height. Adequate calories, protein, and micronutrients such as zinc and vitamin D are needed to support this process, and chronic illnesses can divert energy away from growth toward immune or metabolic demands.

Sleep and daily routines also matter. Growth hormone secretion occurs mainly in deep sleep, so poor sleep quality or chronic stress can reduce effective GH exposure at the growth plate. For this reason, counseling about regular sleep, balanced nutrition, and management of chronic conditions is part of growth care, even when no specific endocrine defect is found.

Finally, anthropometry itself is a “physiology tool”. Accurate, repeated measurements with a proper stadiometer, plotted on appropriate growth charts and compared with mid-parental height, are essential. Many children who appear short at a single visit are later found to be following a stable, familial pattern once data over time are reviewed.


---

3. Pathophysiology and Genetics of Idiopathic Short Stature

ISS was historically seen as a diagnosis of exclusion, but genetic studies show that many children labeled with ISS have subtle molecular defects. Some have single-gene variants affecting growth plate structure, GH secretion, or IGF-1 signaling. Others have complex, polygenic backgrounds where many common variants each contribute a small effect on height. These findings blur the line between “idiopathic” and “monogenic” short stature.
Reference: Dauber A, Rosenfeld RG, Hirschhorn JN. Genetic evaluation of short stature. Nat Rev Endocrinol. 2014;10(10):582–593.

Variants in genes such as ACAN, NPR2, or SHOX can cause proportionate short stature without obvious skeletal deformities, so the child may look “normal but small”. Without genetic testing, these cases are often included under ISS. At the hormonal level, subtle resistance to GH or IGF-1 can lead to poor growth despite apparently normal stimulation test results, because signaling inside the cell is impaired even when hormone levels look adequate.

Epigenetic changes and polygenic risk scores add further complexity. Environmental factors such as intrauterine growth restriction, chronic undernutrition, or psychosocial stress can modify gene expression without altering DNA sequence. This may explain why two children with similar genetic backgrounds and similar heights at one time point can follow very different growth trajectories in the long term.

Clinically, it is useful to think of ISS as a spectrum of overlapping mechanisms rather than a single disease. This perspective supports selective use of genetic testing in children with strong family history, unusual body proportions, or poor response to standard therapy, while acknowledging that many children will still have no clear molecular diagnosis.


---

4. Diagnostic Evaluation and Workup

The evaluation of a child with suspected ISS begins with careful history, physical examination, and auxology before any blood tests are ordered. Key elements include birth weight and length, early feeding and illnesses, chronic symptoms (such as gastrointestinal or respiratory problems), medication use, and a detailed family history of height and pubertal timing. Serial height measurements allow calculation of growth velocity and comparison with mid-parental target height to estimate how far the child is from their genetic expectation.
Reference: Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents. Horm Res Paediatr. 2016;86(6):361–397.

Baseline investigations generally include a complete blood count, renal and liver function tests, thyroid function, celiac screening, and measurement of IGF-1. More specialized tests, such as GH stimulation tests or cortisol assessment, are reserved for children with poor growth velocity or other suggestive clinical features. Bone age radiographs help distinguish constitutional delay from more concerning growth failure and provide an estimate of remaining growth potential.

The ISS label should only be considered once chronic systemic diseases, clear endocrine deficiencies, and obvious syndromic conditions have been reasonably excluded. In selected cases, targeted genetic testing or panel testing is appropriate, especially where there are dysmorphic features, disproportion, or a strong familial pattern. Throughout the evaluation, clear explanations to the family about each step, expected timelines, and reasons for observation prevent misunderstanding and reduce anxiety.

Repeated review every 4–6 months is essential. Growth patterns can change, puberty may start, and new symptoms may emerge. ISS is therefore not a fixed label but a diagnosis that must be revisited as new information becomes available.


---

5. Psychosocial and Quality-of-Life Aspects

Short stature can affect how a child feels about themselves and how others treat them, even when there is no direct physical disability. Studies show that children with marked short stature may report lower self-esteem, more teasing, and limitations in social or school activities, although not every short child experiences these problems to the same degree. The impact often depends on the home environment, school culture, and individual coping style.
Reference: Wheeler PG, Bresnahan K, Shephard BA, Lau J, Balk EM. Short stature and functional impairment: a systematic review. J Pediatr. 2004;144(4):364–370.

Parents and teachers may unintentionally reinforce height-related differences by overprotecting the child or doubting their abilities. This can limit independence and opportunities to develop skills. Educating families and schools to separate height from competence, and to provide age-appropriate responsibilities, can lessen this effect. Simple steps like placing the child in front rows, adapting sports choices, or pairing them with supportive peers can make daily life easier.

Psychology support is valuable when there is bullying, withdrawal, or significant distress about appearance. Counseling can help children reframe height as only one aspect of identity and build strengths in areas where stature is less relevant. Group programs or peer support networks allow them to meet others with similar experiences and reduce feelings of isolation.

For clinicians, asking directly but sensitively about school, friendships, and mood during growth visits ensures that psychosocial issues are not overlooked while focusing on laboratory results and imaging.


---

6. Therapeutic Options and Monitoring

Recombinant human growth hormone (rhGH) is the main pharmacologic treatment for ISS in many countries. On average, it can increase adult height by several centimeters when started in mid-childhood and continued until near final height, but the response is highly variable. Treatment decisions should therefore rely on clear discussion of expected benefits, treatment burden, and uncertainty, rather than only on height standard deviation scores.
Reference: Ranke MB. Growth hormone therapy in idiopathic short stature. Best Pract Res Clin Endocrinol Metab. 2015;29(3):353–366.

Daily subcutaneous injections, regular clinic visits, and the financial cost create a long-term commitment for families. Monitoring includes growth velocity, IGF-1 levels, and periodic bone age, as well as screening for possible adverse effects such as intracranial hypertension, slipped capital femoral epiphysis, and changes in glucose metabolism. If growth response is poor, clinicians should review adherence, injection technique, and the original diagnosis before increasing doses or extending treatment.

Adjunctive options such as gonadotropin-releasing hormone analogues in early or rapidly progressing puberty, or aromatase inhibitors in selected boys, aim to prolong the growth period by slowing bone maturation. These approaches carry their own risks and uncertainties, so they are usually reserved for specific situations and should be discussed in detail with families.

Non-pharmacologic measures remain important throughout therapy. Optimizing nutrition, managing chronic diseases, promoting regular sleep, and supporting mental health help the child make the best use of any growth potential, whether or not rhGH is used. Transition plans for late adolescents should address when to stop treatment, how to follow weight and metabolic health in the future, and how to cope with final adult height.


---

7. Ethics, Health Economics, and Policy

Using rhGH for ISS raises ethical and economic questions. Short stature is at the low end of a normal distribution, not a life-threatening disease, and height gains are usually modest. This leads to debate about whether treating ISS sometimes medicalizes a normal variant and whether high-cost therapy is justified in all cases. Clinicians must weigh possible psychosocial benefits against risks, costs, and the message that being short is inherently a problem.
Reference: Allen DB, Fost N. Growth hormone therapy for short stature: panacea or peril? N Engl J Med. 2004;351(16):1610–1614.

Health-economic analyses show that the cost per centimeter gained in ISS is high. In systems with limited resources, offering rhGH to all eligible ISS patients may compete with other pediatric priorities. As a result, many countries and insurers set strict criteria for height, growth velocity, and predicted adult height before approving treatment. Transparent documentation and shared decision-making help ensure that these rules are applied fairly and that families understand the reasoning behind approvals or denials.

Equity is another concern. Families with more knowledge, time, and resources may push more strongly for evaluation and treatment, while others with similar clinical need may not reach specialty care. Policies that encourage early growth monitoring in primary care, clear referral pathways, and accessible information for parents can reduce this bias.

Ethically sound care also requires honest conversations about uncertainty. Long-term psychosocial benefits are not guaranteed, and there may be pressure—from parents or society—to pursue height at any cost. Clinicians should protect the child’s interests, explain alternatives such as psychological support, and make it clear that declining treatment is a legitimate choice.


---

8. Future Directions and Research Frontiers

New genetic and genomic tools are changing how short stature is classified. Next-generation sequencing, copy number analysis, and studies of gene networks in chondrocytes are identifying novel causes of growth failure. Over time, this is likely to split ISS into smaller, better defined groups with more precise diagnoses and possibly different treatment responses.
Reference: Wit JM, Oostdijk W, Losekoot M, van Duyvenvoorde HA, Ruivenkamp CA, Kant SG. Novel genetic causes of short stature. Eur J Endocrinol. 2016;174(6):R145–R173.

Pharmaceutical research is exploring long-acting GH preparations, new IGF-1 formulations, and agents that target growth plate signaling directly. Long-acting GH aims to reduce injection frequency and perhaps improve adherence, but long-term safety and real-world effectiveness still need careful study. Future therapies may be tailored to specific genetic or signaling defects rather than applying the same regimen to all children with ISS.

Digital health and big-data approaches are likely to influence daily practice. Mobile applications and connected devices can help families track injections, sleep, activity, and growth, generating detailed datasets that can be linked with clinic records. International registries capturing height outcomes, side effects, and patient-reported quality-of-life measures will be essential to refine guidelines and assess cost-effectiveness across different health systems.

At the same time, ethical frameworks must keep pace with these advances. Genomic data sharing, consent for re-analysis of stored samples, and fair access to novel therapies are key concerns. Research should include diverse populations so that new tools benefit children globally, not only those in high-resource settings.


---

9. Conclusion

Idiopathic short stature brings together biological complexity, diagnostic uncertainty, and psychosocial impact. Even when no single cause is found, careful auxology, thoughtful use of investigations, and clear communication allow clinicians to offer meaningful support to children and families. ISS reminds trainees that “not knowing everything” is common in medicine, and that honest follow-up can be more valuable than a rushed label.

Effective management of ISS requires attention to both growth physiology and the child’s daily life. Decisions about rhGH and other interventions should be individualized, balancing potential height gain with treatment burden, cost, and the child’s own priorities as they grow older. Supportive parenting, school understanding, and mental health care can protect well-being regardless of final height.

Looking ahead, advances in genetics, therapeutics, and data science will probably make ISS a less “idiopathic” entity. However, these tools will only be useful if applied within an ethical, patient-centered framework that respects diversity in body size and focuses on the overall health and development of the child, not just the number on the growth chart.
]
"""

HEADING_LINES = {
    "1. Introduction",
    "2. Normal Growth and Physiology",
    "3. Pathophysiology and Genetics of Idiopathic Short Stature",
    "4. Diagnostic Evaluation and Workup",
    "5. Psychosocial and Quality-of-Life Aspects",
    "6. Therapeutic Options and Monitoring",
    "7. Ethics, Health Economics, and Policy",
    "8. Future Directions and Research Frontiers",
    "9. Conclusion",
}


def configure_document(document: Document) -> None:
    """Set up document-wide typography, spacing, and margins."""
    normal_style = document.styles["Normal"]
    normal_style.font.name = "Times New Roman"
    normal_style.font.size = Pt(12)

    normal_format = normal_style.paragraph_format
    normal_format.first_line_indent = Inches(0.25)
    normal_format.space_after = Pt(12)
    normal_format.line_spacing_rule = WD_LINE_SPACING.DOUBLE

    heading_style = document.styles["Heading 1"]
    heading_style.font.name = "Times New Roman"
    heading_style.font.size = Pt(14)
    heading_style.font.bold = True

    for section in document.sections:
        section.top_margin = Inches(1)
        section.bottom_margin = Inches(1)
        section.left_margin = Inches(1)
        section.right_margin = Inches(1)


def extract_title_and_info(lines: list[str]) -> tuple[str, list[str], set[int]]:
    """Identify the title, metadata lines, and indices to omit from the body."""
    title_index = None
    for index, line in enumerate(lines):
        if line.strip() and line.strip() != "[":
            title_index = index
            break
    if title_index is None:
        raise ValueError("Could not determine the title line from the essay text.")

    info_lines: list[str] = []
    for offset in range(1, 5):
        info_index = title_index + offset
        if info_index >= len(lines):
            raise ValueError("Essay text is missing required metadata lines.")
        info_lines.append(lines[info_index])

    remove_indices = set(range(title_index, title_index + 5))
    return lines[title_index], info_lines, remove_indices


def iter_body_paragraphs(lines: list[str], remove_indices: set[int]) -> list[str]:
    """Convert the remaining lines into paragraph strings while preserving order."""
    paragraphs: list[str] = []
    buffer: list[str] = []

    for index, line in enumerate(lines):
        if index in remove_indices:
            continue
        if line == "":
            if buffer:
                paragraphs.append("\n".join(buffer))
                buffer = []
            continue
        buffer.append(line)
    if buffer:
        paragraphs.append("\n".join(buffer))

    return paragraphs


def add_title_page(document: Document, title: str, info_lines: list[str]) -> None:
    """Add the formatted title page to the document."""
    title_paragraph = document.add_paragraph()
    title_paragraph.alignment = WD_ALIGN_PARAGRAPH.CENTER
    title_run = title_paragraph.add_run(title)
    title_run.bold = True
    title_run.font.name = "Times New Roman"
    title_run.font.size = Pt(16)

    for info in info_lines:
        info_paragraph = document.add_paragraph(info)
        info_paragraph.alignment = WD_ALIGN_PARAGRAPH.CENTER
        info_run = info_paragraph.runs[0]
        info_run.font.name = "Times New Roman"
        info_run.font.size = Pt(12)

    document.add_page_break()


def add_body(document: Document, paragraphs: list[str]) -> None:
    """Insert the essay body into the document with appropriate styles."""
    for paragraph_text in paragraphs:
        if paragraph_text in HEADING_LINES:
            document.add_heading(paragraph_text, level=1)
        else:
            paragraph = document.add_paragraph(paragraph_text)
            paragraph.style = document.styles["Normal"]


def main() -> None:
    document = Document()
    configure_document(document)

    lines = ESSAY_TEXT.splitlines()
    title, info_lines, remove_indices = extract_title_and_info(lines)
    body_paragraphs = iter_body_paragraphs(lines, remove_indices)

    add_title_page(document, title, info_lines)
    add_body(document, body_paragraphs)

    document.save("Idiopathic_Short_Stature_Essay.docx")


if __name__ == "__main__":
    main()
